Resistance Exercise and Cognition in People With Type 1 Diabetes

September 7, 2023 updated by: Dr. Ebaa Al Ozairi, Dasman Diabetes Institute

The Effects of Resistance Exercise on Cognition in People With Type 1 Diabetes: a Randomised Controlled Trial

The aim of the current study is to determine the effects of resistance exercise on performance of the Paced Auditory Serial Addition Test and the Colour Trails Test.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Kuwait City, Kuwait, 15462
        • Recruiting
        • Dasman Diabetes Institute
        • Contact:
          • Ebaa AlOZairi
        • Principal Investigator:
          • Ebaa AlOzairi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Physician confirmed type 1 diabetes for at least 1 year
  • Stable insulin therapy for 3 months prior to the study

Exclusion Criteria:

  • BMI of 45 or higher
  • BP of 160/100mmHg or higher
  • autonomic neuropathy
  • severe proliferative retinopathy
  • joint or limb injuries preventing weight-bearing activity
  • autonomic neuropathy
  • severe proliferative retinopathy
  • any other medical condition that prevents participants from exercising safely.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
Habitual Physical Activity
Participants will be asked to maintain their normal activity levels
Experimental: Morning exercise
Exercise training between 6-10am
Between 6-10am participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)
Experimental: Afternoon exercise
Exercise training between 4-8pm
Between 4-8pm participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic change in Paced Auditory Serial Addition Test (PASAT) score
Time Frame: Change from baseline to 12 weeks
Measured using the standardised Paced Auditory Serial Addition Test (PASAT) score ranging from 0-60 with a higher score meaning a better outcome
Change from baseline to 12 weeks
Chronic change in Colour Trails Test score
Time Frame: Change from baseline to 12 weeks
Measured using the standardised Colour Trails Test, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome
Change from baseline to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline acute change in Paced Auditory Serial Addition Test (PASAT) score
Time Frame: Change from before (0 hour) to 1 hour post exercise during week 1
Measured using the standardised Paced Auditory Serial Addition Test (PASAT) during the first exercise session, score ranging from 0-60 with a higher score meaning a better outcome
Change from before (0 hour) to 1 hour post exercise during week 1
12 week acute change in Paced Auditory Serial Addition Test (PASAT) score
Time Frame: Change from before (0 hour) to 1 hour post exercise during week 12
Measured using the standardised Paced Auditory Serial Addition Test (PASAT) during the last exercise session, score ranging from 0-60 with a higher score meaning a better outcome
Change from before (0 hour) to 1 hour post exercise during week 12
Baseline acute change in Colour Trails Test score
Time Frame: Change from before (0 hour) to 1 hour post exercise during week 1
Measured using the standardised Colour Trails Test during the first exercise session, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome
Change from before (0 hour) to 1 hour post exercise during week 1
12 week acute change in Colour Trails Test score
Time Frame: Change from before (0 hour) to 1 hour post exercise during week 12
Measured using the standardised Colour Trails Test during the last exercise session, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome
Change from before (0 hour) to 1 hour post exercise during week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2023

Primary Completion (Estimated)

August 1, 2024

Study Completion (Estimated)

August 1, 2024

Study Registration Dates

First Submitted

July 7, 2023

First Submitted That Met QC Criteria

July 18, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

September 8, 2023

Last Update Submitted That Met QC Criteria

September 7, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on type1diabetes

Clinical Trials on Habitual Physical Activity

Subscribe